Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International Inc. reports developments across its cigarette business and expanding smoke-free portfolio, including IQOS heated tobacco products, ZYN nicotine pouches and e-vapor offerings. Company news commonly covers quarterly results, shipment and revenue trends, product authorizations, brand collaborations, and updates tied to adult-smoker alternatives.
Recurring announcements also address U.S. and international regulatory matters, including FDA modified-risk tobacco product authorizations for IQOS, as well as annual shareholder meetings, board elections, executive compensation votes, auditor ratification, shareholder proposals, and corporate responsibility initiatives.
Philip Morris International (NYSE: PM) received U.S. FDA Modified Risk Tobacco Product (MRTP) orders for 20 ZYN nicotine pouch variants, the first nicotine pouches with such authorization.
FDA authorized marketing the claim that using ZYN instead of cigarettes lowers risk of several smoking-related diseases, following earlier PMTA authorization in January 2025.
Philip Morris International U.S. (NYSE:PM) released Harris Poll findings showing Americans support innovation that delivers tangible local benefits. While 76% say innovation is key to the nation’s future, 79% believe the country is innovating in the wrong areas and 81% see corporate rhetoric as disconnected from real problems.
Respondents prioritize affordability, healthcare access, housing, and good local jobs, and prefer companies that act as long-term community partners. PMI U.S. highlights over $1 billion invested in U.S. manufacturing and operations since 2022 and a workforce of more than 3,300 employees.
Philip Morris International (NYSE:PM) and Maestro Andrea Bocelli launched “Believe. Further”, a multi-year platform to foster dialogue on progress and positive change across Europe. The initiative aligns Bocelli’s personal journey with PMI’s business transformation.
Smoke-free products generated 43% of PMI’s Q1 2026 net revenues, reaching over 43 million legal-age consumers in more than 105 markets. Since 2008, PMI has invested over $16 billion in smoke-free innovation and scientific assessment, and the FDA has authorized marketing and modified-risk claims for certain IQOS, General snus, and ZYN products.
Philip Morris International (NYSE:PM) has been named to the WSJ Leadership Institute’s inaugural “Best Companies for the Future” ranking, placing #97 overall and third in the Food Beverage & Tobacco group.
PMI highlights its smoke-free transformation: smoke-free products in over 105 markets, serving an estimated 43 million adults, generating 43% of Q1 2026 net revenues and supported by over $16 billion invested since 2008 and multiple FDA authorizations.
Philip Morris International (NYSE: PM) and WSJ Intelligence released topline findings of a global study on the growing value of human cognition in an AI-driven workplace. Surveying 2,500 professionals across five countries, the research highlights a “Human Premium” on skills such as creative empathy, critical thinking and ethical judgment.
Key insights include an AI trust gap, risks of cognitive atrophy from overreliance on automation, and a seniority divide in AI proficiency. PMI also underscores its broader transformation, with smoke-free products contributing 43% of first-quarter 2026 net revenues and over $16 billion invested in smoke-free innovation since 2008.
Philip Morris International (NYSE: PM) announced new regional presidents effective August 1, 2026: Marco Hannappel for Europe and Can Kuterdem for Latin America & Canada. They join Gijs de Best and Vassilis Gkatzelis as four regional leaders reporting to PMI International CEO Frederic de Wilde.
PMI highlights progress toward a smoke-free portfolio: smoke-free products represented 43% of first-quarter 2026 net revenues and were used by over 43 million legal-age consumers as of December 31, 2025, following more than $16 billion invested since 2008.
Philip Morris International (NYSE: PM) declared a regular quarterly dividend of $1.47 per share, payable July 20, 2026, to shareholders of record on June 25, 2026; the ex-dividend date is June 25, 2026.
Smoke-free products represented 43% of Q1 2026 net revenues and are used by an estimated 43 million adult consumers. PMI has invested over $16 billion in smoke-free innovation since 2008.
Philip Morris International (NYSE:PM) released KPMG-backed data showing illicit cigarettes reached 10.3% of EU consumption in 2025 (41.8 billion units), implying €16.7 billion in lost tax revenues. Counterfeits rose to 44% of EU illicit volume (18.3 billion), with Western Europe—especially France, Belgium and the Netherlands—most exposed.
PMI highlights contrasting trends in markets such as Greece and Ukraine, calls for evidence-based regulation, and notes its smoke-free products generated 43% of Q1 2026 net revenues and are used by over 43 million adults.
Philip Morris International (NYSE: PM) will present at the 2026 dbAccess Global Consumer Conference and has updated its 2026 EPS outlook.
The company now forecasts reported diluted EPS of $7.18–$7.33 and adjusted diluted EPS of $8.31–$8.46, implying 10.2–12.2% growth versus 2025, including currency and a non-cash RBH impairment.
Philip Morris International (NYSE:PM) will host a live webcast of its presentation and Q&A with CEO Jacek Olczak at the 2026 dbAccess Global Consumer Conference on June 2, 2026, at approximately 11:15 a.m. CET (5:15 a.m. ET).
The webcast, including a replay available for one year, can be accessed via PMI’s website or its free Investor Relations Mobile App. PMI also highlights the growth of its smoke-free portfolio, which represented 43% of first-quarter 2026 net revenues.